The LDN Side Effect Survey Results from 2020 - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)

Jill Brook, MA is a Research Advisor to the LDN Research Trust. In this presentation she shares the results of the 2020 LDN Side Effect Survey.

 

The EMF Toxicity Epidemic - Protection and Treatment - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

 

Longevity - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

 

Developing outcome centric, territory-specific access protocols for the provision of niche product - John Bardsley (2021 Conference) (LDN, low dose naltrexone)

John Bardsley is managing director of Thistle Pharma Ltd. LDN is an unlicensed medicine. Much of what he is talking about pertains specifically to the UK sector, and may apply to your own territories as well.

 

Delivery Systems - Yusuf Saleeby, MD (2021 Conference) (LDN, low dose naltrexone)

In this presentation, Dr. Saleeby discusses different delivery systems for Naltrexone/LDN and ultra low dose Naltrexone, the nuances for the different types of delivery systems, and how to best write a professional compounding prescription.

Terry Wingo - LDN Specialist, LDN Radio Show 20 April 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Terry Wingo graduated from Auburn University in 1975 with a bachelor of science in Pharmacy. He has fellowships with the American College of Apothecaries and the American College of Veterinary Pharmacists.